Cargando…
Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy
Liver resection may be beneficial in intermediate-stage hepatocellular carcinoma (HCC), though the benefit of postoperative anti-hepatitis B virus (HBV) therapy in these patients remains unclear. In this study, we sought to evaluate the efficacy of postoperative anti-HBV for intermediate-stage HCC p...
Autores principales: | Rui, Shaozhen, Yan, Jun, Zhang, Hui, Wang, Zhengfeng, Zhou, Wence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627838/ https://www.ncbi.nlm.nih.gov/pubmed/28746212 http://dx.doi.org/10.1097/MD.0000000000007608 |
Ejemplares similares
-
Impact of MAFLD on the complications after hepatectomy in patients with HBV-related hepatocellular carcinoma
por: Xiong, Ke-Gong, et al.
Publicado: (2023) -
Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy
por: Wang, Zheng-Xia, et al.
Publicado: (2021) -
Survival outcomes of hepatocellular carcinoma resection with postoperative complications – a propensity-score-matched analysis
por: Chok, Kenneth S.H., et al.
Publicado: (2017) -
Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
por: Zheng, Ninggang, et al.
Publicado: (2016) -
Misdiagnosis of hepatic cystic echinococcosis complicated with hepatocellular carcinoma: A case report
por: Wang, Zheng, et al.
Publicado: (2022)